ExploreWatchlistsPricing
  1. JP-listed companies
  2. CellSeed Inc.
  3. Financials
  4. Total current assets

CellSeed Inc. (7776)

Market cap
¥11.5B
P/E ratio
-9.8x
Cellseed develops cell sheet regenerative medicine technology to treat diseases that conventional therapies cannot cure, serving researchers and patients globally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Dec 31, 20251,522-34.20%
Dec 31, 20242,312-1.68%
Dec 31, 20232,352+90.90%
Dec 31, 20221,232+12.57%
Dec 31, 20211,094-32.54%
Dec 31, 20201,622+30.25%
Dec 31, 20191,245-17.26%
Dec 31, 20181,505+1.89%
Dec 31, 20171,477+17.30%
Dec 31, 20161,259-42.32%
Dec 31, 20152,183-27.66%
Dec 31, 20143,018

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat